As providers continue to consolidate and adopt practices that make them look increasingly like payers, decision-making about products and services is moving away from clinicians and involving more people. In addition, with recent guidance on FDAMA 114, manufacturers have been given new latitude to share health economic information with decision makers to support their value story.
In this environment, manufacturers must rethink their approach to the market and how they use data to demonstrate value in the eyes of stakeholders. Determining which data to use, how to communicate it, who should receive it and who will deliver it are challenges to be addressed. This session will provide insight into strategies some manufacturers are using to adapt to meet growing demands from stakeholders for a data-based value narrative.

Ability Level: Intermediate

Session ID: 20997